Lilly sees slower profit growth in 2007
628463
Eli Lilly and Co.  forecast profit gains next year below its expected 2006 growth of 8 percent to 12 percent, held back by higher costs.
318137
Net profit dropped at the consumer products maker to 721 million euros ($1.04 billion) in the last three months of 2007, from 2.03 billion euros a year earlier.
187282
DuPont Co. , the No. 2 U.S. chemical maker, on Tuesday posted a lower quarterly profit after a large tax gain a year earlier and forecast earnings growth in 2005.
515541
INDIANAPOLIS, July 24  â Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Streetâs second-quarter expectations Tuesday, although profits fell 19 percent at the pharmaceutical company because of acquisition costs.
675913
Eli Lilly and Co. said its strategy of staying independent and plowing money into research should pay off in 2005, with profits expected to jump 8 percent to 12 percent over 2004 and nine new drugs in advanced human testing.
102028
Sanofi-Aventis  posted higher than expected fourth-quarter profits on Tuesday and predicted more growth for 2007, but a further delay in its key new anti-obesity drug Acomplia hit the shares.
712690
Eli Lilly &amp; Co. said Thursday it expects 2005 earnings, excluding the impact of expensing stock options, to be in line with analysts&#39; views.
150665
Drugstore chain Rite Aid Corp. RAD.N  on Tuesday warned that full-year profit and revenue would fall  short of Wall Street expectations because of slowing pharmacy  sales as companies try to curb health-care costs.
299049
Eli Lilly and Co.  on Tuesday  posted better-than-expected second-quarter earnings helped by  surging sales of its prescription drugs, including depression  treatment Cymbalta, and the company raised its 2007 profit  forecast.
743307
German premium carmaker BMW reported a lower-than-expected 7.6 percent rise in third-quarter pretax profit, but reaffirmed its forecast for record revenues, earnings and car sales in 2004.
684827
Wal-Mart expects slower sales growth over the next three years and will spend less on new stores.
154967
Eli Lilly and Co. LLY.N on Wednesday  reported a fourth-quarter net loss on charges for restructuring  and taxes related to the return of overseas profits, as sales  of prescription drugs rose only slightly.
501273
Merck & Co. on Wednesday maintained its forecast of flat earnings for 2006 and slightly higher 2007 results as the drugmaker grapples with generic competition, sending its shares down about 1.4 percent.
280260
The economy could be headed for slower growth in the next several months, according to a report released Thursday by a private research group.
170213
Drug wholesaler says earnings to come below Wall Street estimates; cites slower drug price hikes. NEW YORK  - AmerisourceBergen Corp.
95372
Sanofi-Aventis posted higher than  expected fourth-quarter profits on Tuesday and predicted more  growth for 2007, but a further delay in its key new  anti-obesity drug Acomplia hit the shares.
468404
Eli Lilly and Co. LLY.N on Thursday  said it expects 2005 earnings to rise as higher sales of its  newer drugs offset a decline in its top-selling schizophrenia  drug Zyprexa.